Rapid Virologic Response: A New Milestone in the Management of Chronic Hepatitis C | Zendy

Fred Poordad | Zendy; K. Rajender Reddy | Zendy; Paul Martin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Rapid Virologic Response: A New Milestone in the Management of Chronic Hepatitis C

Author(s) -

Fred Poordad,

K. Rajender Reddy,

Paul Martin

Publication year - 2007

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/523585

Subject(s) - medicine , ribavirin , regimen , hepatitis c virus , pegylated interferon , hepatitis c , viral load , milestone , immunology , gastroenterology , virus , archaeology , history

Rapid virologic response (RVR), defined as an undetectable serum hepatitis C virus (HCV) RNA level at week 4 of treatment, is emerging as an important milestone in the treatment of patients who have chronic hepatitis C by use of pegylated interferon-alfa and ribavirin--the current standard of care. This assessment is being used to individualize treatment duration, which is currently recommended as 48 weeks in patients infected with HCV genotype 1 (G1) and 24 weeks in those infected with HCV G2 or G3.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research